BioNTech Gets Gates Foundation Funding For HIV, TB Drug Discovery

The Bill & Melinda Gates Foundation has invested $55m in an infectious disease collaboration with Germany’s BioNTech that could reach up to $100m in total funding.

Lab
Duo’s plan is to tap BioNTech’s mRNA-based approach for fighting HIV, TB • Source: Shutterstock

More from Business

More from Scrip